Aclaris Therapeutics Files 8-K
Ticker: ACRS · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1557746
| Field | Detail |
|---|---|
| Company | Aclaris Therapeutics, INC. (ACRS) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, disclosure
Related Tickers: ACRS
TL;DR
Aclaris Therapeutics filed an 8-K on 7/29/25 for disclosures and other events.
AI Summary
On July 29, 2025, Aclaris Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Aclaris Therapeutics is making a regulatory disclosure and reporting on other events, which could include significant business updates.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material information that would indicate a change in risk.
Key Players & Entities
- Aclaris Therapeutics, Inc. (company) — Registrant
- July 29, 2025 (date) — Date of earliest event reported
- 701 Lee Road, Suite 103 Wayne, PA 19087 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Aclaris Therapeutics?
The 8-K filing is for Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on July 29, 2025.
What is the principal executive office address for Aclaris Therapeutics?
The principal executive office is located at 701 Lee Road, Suite 103, Wayne, PA 19087.
What is the company's state of incorporation?
Aclaris Therapeutics, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number for Aclaris Therapeutics?
The IRS Employer Identification Number is 46-0571712.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Aclaris Therapeutics, Inc. (ACRS).